This week in Ozempic news: No more compounded GLP-1s, weight-loss pills are coming, and WeightWatchers is filing for ...

Despite the decision being a win for Novo Nordisk, the compounded drugs sector is far too complex for this to be a final ...

Novo Nordisk scored a legal win against compounders of its blockbuster GLP-1 drugs. But it may not end the copycats.

Since the reversal of Roe v. Wade, the number of abortions is up because of telehealth and the free sharing of mifepristone ...

Oral finasteride is an FDA-approved medication designed to help prevent hair loss. It specifically blocks type‑II ...

Commissioner Marty Makary said he has no plans to change current policy to restrict access to the abortion pill mifepristone, ...

A federal judge in Texas handed Novo Nordisk (NVO) a big win late Thursday in its battle against cheaper versions of its ...

Hims & Hers (HIMS) stock in focus as a U.S. court denies injunction to continue making cheap versions of Novo Nordisk's (NVO) ...

Many compounding pharmacies are no longer allowed to make cheaper versions of semaglutide and other GLP-1 drugs. A doctor ...

The Food and Drug Administration is planning to push crucial medication information online, and a broadband subsidy program ...

Patients flocked to those Ozempic, Wegovy copycats when the branded drugs were in short supply, or if they didn’t have ...